Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC O-16:0/22:3)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003760 AN006175 Untargeted lipidomics of combination gemcitabine/paclitaxel attenuated (CombAT) PDAC cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003757 AN006169 Untargeted lipidomics of gemcitabine-resistant PDAC cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003678 AN006039 The effects of cystine limitation stress adaptation (CLSA) on lipidomics changes in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST003629 AN005961 Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells T-cells Human Brain disease Leibniz Institute for Plasma Science and Technology LC-MS
ST003157 AN005179 Diet modulates the protective effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCA2 - Lipidomics Blood Mouse Multiple sclerosis University of Luebeck LC-MS
ST002145 AN003511 The Carbohydrate Sensing Transcription Factor ChREBP Links Mitochondrial Lipidomes to Mitochondrial Dynamics and Progression of Diabetic Nephropathy Cultured cells Mouse Diabetes University of Texas MD Anderson Cancer Center LC-MS
ST002145 AN003512 The Carbohydrate Sensing Transcription Factor ChREBP Links Mitochondrial Lipidomes to Mitochondrial Dynamics and Progression of Diabetic Nephropathy Cultured cells Mouse Diabetes University of Texas MD Anderson Cancer Center LC-MS
ST001405 AN002347 MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models Cultured cells Human Ohio State University LC-MS
  logo